Dow restricts new GMOs to avoid upsetting Chinese trade

Dow AgroSciences’ decision to severely restrict U.S. introduction of its Enlist genetically modified crops and herbicide – billed as the company’s most important product launch ever – came after extensive talks with U.S. grain leaders who fear roiling trade with China, a company executive said last Thursday.

Over the last year, China has shown reluctance to approve new GMO grain for import and has rejected more than 1 million tonnes of U.S. corn containing traces of unapproved GMO traits.

Dow AgroSciences’ application for Chinese approval of its Enlist genetically modified corn has languished for about two years. Its Enlist soybeans are also awaiting approval. Both are genetically engineered to withstand treatments of Dow’s new Enlist Duo herbicide.

Joe Vertin, Dow AgroSciences’ global leader for Enlist, said after the company received U.S. regulatory approvals this fall it held talks with national corn and soybean grower groups, grain trading groups and others on how to proceed.

The “unique” strategy unveiled on Wednesday, allows only for seed production of its new Enlist soybeans. Farmers who grow Enlist corn seed will be required to feed the harvested grain to their livestock and agree to have the process audited. Farmers will be invoiced for Enlist corn seed only after China import approval is granted.

Read the full, original article: Limited GMO crop launch is ‘unique’ reaction to China -Dow official

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Jul-8-2026-12_32_48-PM
Viewpoint: SCOTUS strikes a blow against junk science in Bayer glyphosate case. Will it deter mass tort litigators?
ChatGPT-Image-Jul-7-2026-01_57_55-PM
Viewpoint: Europe’s rejection of air conditioning is the poster child for misunderstanding how to mitigate the impact of climate change
ChatGPT-Image-Jul-1-2026-12_37_08-PM
Viewpoint: Trump poised to politicize all U.S.-supported science research
Screen-Shot-at-PM-pe-vra-kipgaprbdo-vd-ms-jpule-n-jqqaxf-l-e
Viewpoint: Will new breeding techniques help make European agriculture more competitive?
Screenshot-2026-07-08-at-11.25.14-AM
AI being mobilized to target misinformation about vaccines–on AI
Screenshot-2026-07-08-at-2.14.27-PM
Belief in unproven dietary regimes, vitamins, and crank therapies is putting patients’ health in danger and increasing the risk of getting cancer
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Jul-1-2026-03_33_49-PM
‘Alternative’ cancer treatments that could kill you
ChatGPT-Image-Jul-10-2026-09_12_58-AM
X rolls out direct messages to users who interact with misinformation
ChatGPT-Image-Jun-30-2026-10_27_31-AM
Viewpoint: Europe clears the way for gene-edited crops — but fear-driven restrictions still slow their full potential
ChatGPT-Image-Jul-7-2026-12_01_35-PM
Viewpoint: 21 worthless wellness trends inspired by RFK, Jr.’s ill-informed MAHA followers that can harm or even kill you.
DtAieAIkCZy-uchn-oqg
Viewpoint: In the science misinformed grifter game plan, the organic-food-is-healthier myth might be the worst.
ChatGPT-Image-Jul-7-2026-03_07_17-PM
Kennedy blocks preventive health care panel that reviews treatments for HIV, diabetes, and cancer from meeting — for fourth time
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.